The continuing CRISPR patent saga
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
CRISPR has the potential to be one of the most revolutionary (or dangerous) genetic manipulation technologies ever developed.
It provides researchers with the ability to “edit” genetic information (including both structural genes encoding proteins as well as regulatory sequences that control when a gene is expressed, how much, and in what tissue) in ways heretofore only more crudely practiced; for example, by introducing a heterologous gene into a new cellular environment. It thus has implications for agriculture — increasing yield, for example, or reducing allergens like gluten — as well as human medicine.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters